advanced kidney cancer
Showing 1 - 25 of >10,000
Kidney Cancer Trial in Tampa, Atlanta, Nashville (Blood Sparing Protocol, Standard Blood Replacement)
Suspended
- Kidney Cancer
- Blood Sparing Protocol
- Standard Blood Replacement
-
Tampa, Florida
- +2 more
Aug 26, 2022
Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))
Completed
- Kidney Cancer
- Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Advanced Kidney Cancer Trial in Tianjin (Pembrolizumab plus Lenvatinib)
Recruiting
- Advanced Kidney Cancer
- Pembrolizumab plus Lenvatinib
-
Tianjin, Tianjin, ChinaChangyi Quan
Aug 4, 2022
Advanced Kidney Cancer Trial in Tianjin (Tislelizumab Lenvatinib)
Recruiting
- Advanced Kidney Cancer
- Tislelizumab Lenvatinib
-
Tianjin, Tianjin, ChinaChangyi Quan
Aug 4, 2022
Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)
Active, not recruiting
- Advanced Kidney Cancer
- +2 more
-
Chicago, Illinois
- +4 more
Feb 16, 2022
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)
Available
- Clear Cell Kidney Cancer
- +2 more
- Axitinib 5 MG
- (no location specified)
Jul 3, 2023
Kidney Cancer Trial in Houston (Axitinib)
Active, not recruiting
- Kidney Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2022
Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)
Recruiting
- Renal Cancer
- Magnetic Resonance Imaging (MRI) Scan
- Tc-99m Pentetate
-
New York, New YorkNYU Langone Health
Oct 31, 2023
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium
Active, not recruiting
- Advanced Renal Cell Carcinoma
- +5 more
- Clostridium butyricum CBM 588 Probiotic Strain
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),
Recruiting
- Solid Tumor, Adult
- +19 more
- SNS-101 (anti-VISTA)
- Cemiplimab
-
Irving, Texas
- +2 more
May 24, 2023
Kidney Cancer Trial in Cambridge (Magnetic Resonance Imaging)
Recruiting
- Kidney Cancer
- Magnetic Resonance Imaging
-
Cambridge, Cambridgeshire, United KingdomUniversity Department of Radiology
Aug 23, 2023
Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose
Not yet recruiting
- Cancer
- +16 more
- KVA12123 - Dose Escalation
- +3 more
- (no location specified)
Feb 2, 2023
Describe Kidney Cancer Patient Population Treatment, and Results
Not yet recruiting
- Renal Cell Cancer
- +6 more
- (no location specified)
May 2, 2022
Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))
Completed
- Renal Cell Carcinoma
- +3 more
- Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)
Not yet recruiting
- Cancer
- +8 more
- DK210 (EGFR)
- +3 more
- (no location specified)
Jan 27, 2023
oncRNA Stratification of Cancer by Size and Stage
Not yet recruiting
- Kidney Cancer
- +32 more
- Exai oncRNA blood test
- (no location specified)
Apr 27, 2023
Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 5, 2022
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 2, 2022